BOTOX® Cosmetic Selects This Year's Entrepreneurs for The Confidence Project Pharmaceutical Investing
Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025 Life Science Investing
Medtronic secures CE Mark for MiniMed 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes Life Science Investing
Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET Life Science Investing
Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling Life Science Investing
Ichnos Glenmark Innovation and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody Pharmaceutical Investing
AbbVie and Ichnos Glenmark Innovation Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody Pharmaceutical Investing
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence Pharmaceutical Investing
